FDA-Approved AI Devices for Eye Care: Full List 2026
The FDA-cleared AI diagnostic devices for optometry and ophthalmology in 2026, including retinal, glaucoma and diabetic screening tools.
The FDA-cleared AI diagnostic devices for optometry and ophthalmology in 2026, including retinal, glaucoma and diabetic screening tools.
How optometry EHR interoperability connects your practice with hospitals, primary care, and specialists. What to look for in 2026.
How AI screening tools help optometrists triage referrals more accurately, cutting unnecessary specialist visits and improving outcomes.
AI-powered glaucoma detection software is changing how optometrists identify and monitor the disease. Here are the top platforms in 2026.
Connect telehealth with Eyefinity, RevolutionEHR, Compulink or OfficeMate: integration options, data flow and avoiding documentation gaps.
An in-depth OfficeMate EHR review covering features, pricing, integrations, and whether it's the right choice for your optometry practice in 2026.
The complete guide to teleoptometry software in 2026: compare platforms, understand reimbursement, and launch remote eye care services.
Compare the top AI retinal screening platforms for optometrists: accuracy, workflow integration and FDA clearance status, in this 2026 guide.
Detailed comparison of Humphrey, Octopus, and FDT visual field software. Which perimetry platform best fits your glaucoma monitoring workflow in 2026?
Explore how AI and machine learning are revolutionizing optometry in 2026, from automated refraction to early disease detection.
Get new articles on optometry and eye care delivered to your inbox. No spam, unsubscribe any time.
We'll send a confirmation email. No spam ever.